US Patent Issued to GUANGZHOU REFORGENE MEDICINE, ZHEJIANG SYNSORBIO TECHNOLOGY on May 13 for "CRISPR-Cas13 system and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., June 12 -- United States Patent no. 12,297,450, issued on May 13, was assigned to GUANGZHOU REFORGENE MEDICINE Co. LTD. (Guangzhou, China) and ZHEJIANG SYNSORBIO TECHNOLOGY Co. LTD (Shaoxing, China).

"CRISPR-Cas13 system and use thereof" was invented by Junbin Liang (Guangdong, China), Xingxiang Liang (Guangdong, China), Yang Sun (Zhejiang, China), Hui Xu (Guangdong, China), Kaiwei Si (Guangdong, China), Qiuting Li (Guangdong, China), Zhiqin Peng (Guangdong, China) and Desheng Huangfu (Guangdong, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a CRISPR-Cas13 system and use thereof, and also relates to a Cas13 protein, a fusion protein, and a guide polynu...